Preventing MSDs in the Pharmaceutical Industry – Infographic
With over 100,000 employees and thousands of laboratories across France, the pharmaceutical industry is a strategic player in our economy. While innovation, precision, and quality are at the heart of its operations, working conditions expose teams to numerous physical, organizational, and psychosocial risks — often leading to musculoskeletal disorders (MSDs).
🔬 Discover the main risk factors in our dedicated infographic:
Identifying risks to take sustainable action
In the face of these challenges, prevention can no longer rely on mere observations.
Because your employees should never have to choose between their job and their health, Moovency offers KIMEA — a suite of innovative, high-performance solutions that support you in evaluating and optimizing workstation ergonomics.
We support pharmaceutical manufacturers through a concrete and measurable prevention approach. Adopting a mindset of continuous optimization ensures the highest standards are maintained while constantly improving employee well-being — helping companies stay ahead of the curve.
We also offer training services. Your internal teams are trained to use our KIMEA tools to assess workstation risks autonomously. This means you’re no longer dependent on external providers for physical risk measurement. Ergonomists can then be brought in only when facing complex situations that require expert analysis.
A tool like KIMEA is ideal for ensuring that your workstations are optimised over time: thanks to the KIMEA score and visual indicators, you can assess your progress at a glance.
Preventing MSDs means protecting the men and women who make up the strength of the pharmaceutical industry. It’s also a concrete way of building loyalty, attracting new recruits and boosting the performance of the entire sector!